{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T22:08:20Z","timestamp":1649023700843},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.arcped.2009.07.020","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T09:12:44Z","timestamp":1257498764000},"page":"1607-1611","source":"Crossref","is-referenced-by-count":2,"title":["Nouveaut\u00e9s pharmaceutiques dans l\u2019arthrite juv\u00e9nile idiopathique"],"prefix":"10.1016","volume":"16","author":[{"given":"B.","family":"Bader-Meunier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Quartier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2009.07.020_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France","volume":"67","author":"Lequerr\u00e9","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"Suppl.","key":"10.1016\/j.arcped.2009.07.020_bib2","first-page":"S632","volume":"58","author":"Quartier","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2009.07.020_bib3","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2009.07.020_bib4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2009.07.020_bib5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jpeds.2004.08.020","article-title":"Thalidomide for severe systemic-onset juvenile rheumatoid arthritis: a multicenter study","volume":"145","author":"Lehman","year":"2004","journal-title":"J Pediatr"},{"issue":"Suppl. 1","key":"10.1016\/j.arcped.2009.07.020_bib6","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1038\/sj.bmt.1703946","article-title":"Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis","volume":"32","author":"Wulffraat","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.arcped.2009.07.020_bib7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2009.07.020_bib8","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2009.07.020_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2007.087593","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Preliminary data from the German etanercept registry for treatment of juvenile","volume":"68","author":"Horneff","year":"2009","journal-title":"Arthritis Rheum Dis"},{"key":"10.1016\/j.arcped.2009.07.020_bib10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2009.07.020_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2009.07.020_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2006.103721","article-title":"Adalimumab in the therapy of uveitis in childhood","volume":"91","author":"Biester","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.arcped.2009.07.020_bib13","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1210\/jc.2006-2877","article-title":"Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study","volume":"92","author":"Simon","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcped.2009.07.020_bib14","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1210\/jc.2007-0544","article-title":"Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study","volume":"92","author":"Bechtold","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcped.2009.07.020_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/adc.2006.093997","article-title":"Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis","volume":"91","author":"Thornton","year":"2006","journal-title":"Arch Dis Child"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X09003200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X09003200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T14:51:59Z","timestamp":1544885519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X09003200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0929693X09003200"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2009.07.020","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}